Prevalence of persistent blood eosinophilia: Relation to outcomes in patients with COPD

European Respiratory Journal

Volumn 50, Issue 5, 2017, Pages

  Casanova, Ciro ^a   Celli, Bartolome R ^b   de Torres, Juan P ^c   Martínez Gonzalez, Cristina ^d   Cosio, Borja G ^e,f   Pinto Plata, Victor ^g   de Lucas Ramos, Pilar ^h   Divo, Miguel ^b   Fuster, Antonia ⁱ   Peces Barba, Germán ^f,j   Calle Rubio, Myriam ^k   Solanes, Ingrid ^l   Aguero, Ramón ^m   Feu Collado, Nuria ⁿ   Alfageme, Inmaculada ^o   de Diego, Alfredo ^p   Romero, Amparo ^q   Balcells, Eva ^r   Llunell, Antonia ^s   Galdiz, Juan B ^t   Marin, Margarita ^u   Moreno, Amalia ^v   Cabrera, Carlos ^w   Golpe, Rafael ^x   Lacarcel, Celia ^y   Soriano, Joan B ^z   López Campos, José Luis ^f,aa   Soler Cataluña, Juan J ^ab   Marin, José M ^ac   more..

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g BAYSTATE MEDICAL CENTER   (United States)

^h HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

ⁱ HOSPITAL SON LLÀTZER   (Spain)

^j Instituto Reina Sofía de Investigación Nefrológica   (Spain)

^k SCHOOL OF MEDICINE   (Spain)

^l UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^m HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁿ HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^o HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^p HOSPITAL UNIVERSITARIO LA FE   (Spain)

^q HOSPITAL DE MANACOR   (Spain)

^r HOSPITAL DEL MAR   (Spain)

^s HOSPITAL DE TERRASSA   (Spain)

^t HOSPITAL DE CRUCES   (Spain)

^u HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^v HOSPITAL DE SABADELL   (Spain)

^w HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^x HOSPITAL UNIVERSITARIO LUCUS AUGUSTI   (Spain)

^y Hosp Univ Ciudad de Jaén   (Spain)

^z HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^aa HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^ab HOSPITAL ARNAU DE VILANOVA   (Spain)

^ac HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE EXACERBATION; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTOR; SMOKING; TREATMENT OUTCOME; COMPLICATION; CYTOLOGY; EOSINOPHIL; LEUKOCYTE COUNT; PATHOPHYSIOLOGY; SPAIN; SURVIVAL ANALYSIS;

AGED; COHORT STUDIES; DISEASE PROGRESSION; EOSINOPHILIA; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS;

EID: 85041230640     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01162-2017     Document Type: Article

References (30)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
2. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182: 598-604.
3. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol 2017; 53: 324-335.
4. Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005; 60: 193-198.
5. Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184: 662-671.
6. Singh D, Kolsum U, Brightling CE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J 2014; 44: 1697-1700.
7. Negewo NA, McDonald VM, Baines KJ, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis 2016; 11: 1495-1504.
8. Siddiqui SH, Guasconi A, Vestbo J, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192: 523-525.
9. Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med 2015; 3: 435-442.
10. Pavord ID, Lettis S, Locantore N, et al. Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD. Thorax 2016; 71: 118-125.
11. Barnes NC, Sharma R, Lettis S, et al. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD. Eur Respir J 2016; 47: 1374-1382.
12. Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med 2016; 4: 390-398.
13. Vedel-Krogh S, Nielsen SF, Lange P, et al. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population Study. Am J Respir Crit Care Med 2016; 193: 965-974.
14. Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38: 709-750.
15. López-Campos JL, Peces-Barba G, Soler-Cataluña JJ, et al. Chronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. Study methods and organization. Arch Bronconeumol 2012; 48: 453-459.
16. Celli BR, Cote C, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
17. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
18. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735.
19. American Thoracic Society. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
20. Mahler DA, Weels CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580-586.
21. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
22. Sin DD, Hollander Z, DeMarco ML, et al. Biomarker development for chronic obstructive pulmonary disease. from discovery to clinical implementation. Am J Respir Crit Care Med 2015; 192: 1162-1170.
23. Marks-Konczalik J, Costa M, Robertson J, et al. A post-hoc subgroup analysis of data from a six-month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophils. Respir Med 2015; 109: 860-869.
24. Suzuki M, Makita H, Konno S, et al. Asthma-like features and clinical course of chronic obstructive pulmonary disease. an analysis from the Hokkaido COPD Cohort Study. Am J Respir Crit Care Med 2016; 194: 1358-1365.
25. Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J 2016; 48: 664-673.
26. Oshagbemi OA, Burden AM, Braeken DCW, et al. Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts. Am J Respir Crit Care Med 2017; 195: 1402-1404.
27. Meijer RJ, Kerstjens AM, Arends RL, et al. Effect of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 1999; 54: 894-899.
28. Kreindler JL, Watkins ML, Lettis S, et al. Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD. BMJ Open Respir Res 2016; 3: e000151.
29. Zysman M, Deslee G, Caillaud D, et al. Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis 2017; 12: 1819-1824.
30. Pavord ID, Lettis S, Anzueto A, et al. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis. Lancet Respir Med 2016; 4: 731-741.